Transparency Market Research (TMR) has
published a new report titled, “Acute Lymphoblastic Leukemia Market - Global Industry Analysis,
Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to
the report, the global acute lymphoblastic leukemia market was
valued at US$ 1,627.5 Mn in 2017. It is projected to expand at a CAGR of 8.1%
from 2018 to 2026. Expansion of the pharmaceutical industry, government
initiatives, increase in health care expenditure, surge in research &
development, and rise in patient population are anticipated to augment the
global market from 2018 to 2026.
Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=22886
Increase in Patient Population to
Propel Market
Acute lymphoblastic leukemia, one of four major types of leukemia,
is a blood cancer that starts in the bone marrow and spreads into the blood,
rapidly. Acute lymphoblastic leukemia is an aggressive type of leukemia, which
requires early treatment; without treatment, most patients with acute leukemia
would live only a few months. Acute lymphoblastic leukemia is more common among
children aged above five. Increase in patient population for acute
lymphoblastic leukemia propels the market. According to recent study, around
412,000 people worldwide are likely to be diagnosed with some type of leukemia,
and acute lymphoblastic leukemia accounts for approximately 12% of all leukemia
cases worldwide. According to the American Society of Clinical Oncology (ASCO),
nearly 5,970 cases of acute lymphoblastic leukemia (ALL) were reported in the
U.S. in 2017.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22886
Rise in Number of New Product
Approvals and Clinical Trials
Demand for therapeutics for acute lymphoblastic leukemia has
increased in the last few years. This has resulted in the rise in new product
approval and number of clinical trials in late and early phases of drug development.
For instance, in August 2018, Novartis AG received approval from the European
Commission for its CAR-T cell therapy (Kymriah) for B-cell acute lymphoblastic
leukemia. For instance, in 2017, Baylor College of Medicine started conducting
phase 1 clinical trials of CD5.CAR/28zeta CAR T cells, Cytoxan for T-cell acute
lymphoblastic leukemia. The study is expected to be complete by June 1, 2036.
Request for
Analysis of COVID19 Impact on Acute Lymphoblastic Leukemia Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=22886
High Cost of Treatment to Restrain
Market
Rise in scientific and technological advancements in R&D and
manufacturing processes is projected to increase the efficiency of drug
development. However, high cost associated with the treatment of acute
lymphoblastic leukemia is anticipated to restrain the market during the
forecast period. Development of therapeutics require the utilization of
expensive instrumentation, which in turn increases the overall cost of
therapeutics and treatment for the disease. For instance, the cost of
chemotherapeutic Arranon (Nelarabine) is between US$ 75,000 and US$ 100,000 in
the U.S.
Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=22886
Asia Pacific Market to Expand Significantly
In terms of revenue, the acute lymphoblastic leukemia market in
Asia Pacific is projected to expand at a high CAGR during the forecast period.
Rapidly increasing patient population in the region is expected to boost the
demand for therapeutics for the treatment of acute lymphoblastic leukemia.
This, in turn, is likely to drive the market from 2018 to 2026. Increase in
government expenditure on health care is anticipated to fuel the acute
lymphoblastic leukemia market in Asia Pacific during the forecast period. For
instance, according to India’s Union Budget 2017–2018, the total health care
expenditure was increased from 1.97% to 2.27% of the total union budget.
Buy now Acute
Lymphoblastic Leukemia Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=22886<ype=S
Novartis AG and Pfizer, Inc. to
Lead Market
The report also provides profiles of leading players operating in
the global acute lymphoblastic leukemia market. These include Sanofi, Pfizer,
Novartis AG, F. Hoffmann-La Roche Ltd., Sanofi, Erytech Pharma, Inc., Celgene
Corporation, Amgen, Inc. Bristol-Myers Squibb Company, and Spectrum
Pharmaceuticals, Inc. Increase in mergers & acquisitions, strategic
collaborations, surge in clinical trials, and new product launches are expected
to drive the global market during the forecast period. For instance, in January
2017, Novartis AG signed collaborative agreements with various key industry
players to co-develop and co-commercialize oncology therapies.
More Trending Reports by
Transparency Market Research:
https://www.prnewswire.com/news-releases/numerous-players-in-ultrasound-gels-market-lean-on-innovation-in-formulation-for-surgical-lubricant-gels-acceptance-of-silicon-solutions-in-medical-devices-spurs-prospects-tmr-301266741.html
https://www.prnewswire.com/news-releases/projected-rise-of-prevalence-of-osteoporosis-in-numerous-regions-drive-demand-for-new-treatment-options-for-osteoporosis-drugs-market-tmr-301271544.html
https://www.prnewswire.com/news-releases/new-engineering-approaches-in-vascular-grafts-market-expands-horizon-of-endovascular-surgeries-synthetic-products-attract-rd-tmr-301278115.html
About Us
Transparency Market Research is a global market intelligence
company, providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. Our experienced team
of Analysts, Researchers, and Consultants, use proprietary data sources and
various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team
of research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability, Transparency Market
Research employs rigorous primary and secondary research techniques in
developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
